Investigation & Intelligence Feeds
Global Employment Trends And What’s Ahead: 2025 In Review And 2026 Preview
Global employers are preparing for a new era of workforce planning, compliance, and innovation. Economic and geopolitical uncertainty, ...
Where Microsoft Purview Fits in the Microsoft 365 Compliance Stack: eDiscovery Trends
In this post, Shelley Bougnague of Cloudficient discusses where Microsoft Purview fits in the Microsoft 365 compliance stack and where ...
The Lokken v. UHC Discovery Battle and What It Means for Insurers Using AI
The federal court discovery battle in Estate of Lokken v. UnitedHealth Group (UHC) (see complaint here) at Docket # 2023-cv-03514 (D. M...
New Executive Order Aims To Preempt State AI Regulation: Top Points
On December 11, 2025, President Donald Trump signed an Executive Order (EO) titled, “Ensuring a National Policy Framework for Artificia...
Alberta Energy Regulator Announces New Editions of Directive 071 and Manual 026
Building on our previous blog regarding the AERH2S model, this update addresses the new editions of Alberta Energy Regulator (AER) Dire...
Taiwan Passes Major Amendments to the Personal Data Protection Act
On November 11, 2025, amendments to Taiwan's Personal Data Protection Act ("PDPA") were promulgated by the president. Although the amen...
Incoming Lithium-Ion Battery Regulations—Health Canada Wants to Hear from You
On December 2, 2025, Health Canada published a Notice of Intent regarding proposed regulations for lithium-ion batteries and consumer p...
Reminder for the 2026 eDiscovery Today State of the Industry Survey!: eDiscovery Trends
Reminder that the 2025 eDiscovery Today State of the Industry Report Survey (again sponsored by EDRM) is still active! Please consider ...
European Commission’s Proposal to Amend the MDR and IVDR
The European Commission has published the long-awaited proposal amending Regulations (EU) 2017/745 (the “MDR”) and (EU) 2017/746 (the “...
FDA Removes Significant Barrier to Using Real-World Evidence in Product Submissions
The U.S. Food and Drug Administration announced a major shift in its approach to real‑world evidence (RWE). In new guidance for certain...